Literature Request




	What Is Venofer^®?
	Guidelines for Anemia Management
	Clinical Pharmacology
	Indications and Dosage
	Efficacy and Safety
	Pharmacy Specifications
	Current Issues
	Reimbursement & Patient Assistance Program
	Additional Resources


	Iron Deficiency
	Chronic Renal Failure
	Managing Iron Deficiency Anemia
	Key Learnings


	Learn More About Venofer® (iron sucrose injection, USP) and Iron Deficiency Anemia To register or request information about Venofer^® (iron sucrose injection, USP) and iron deficiency anemia, please fill out this form and click the submit button. Please allow 2 to 4 weeks for delivery. Updates about Venofer^® will be sent to you when they become available. Journal Article Reprints Van Wyck D, Cavallo G, Spinowitz B, Adhikaria R, Gagnon S, Charytan C, et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis. 2000;36:88-97. Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S, Van Wyck D. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis. 2001;37:300-307. Aronoff G, Bennett W, Blumenthal S, Charytan C, et al. Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens. Kidney Int'l. 2004;66:1193-1198. Charytan C, Schwenk M, Al-Saloum M, Spinowitz B. Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. Nephron, 2004;96:c63-c66. Van Wyck D, Anderson J, Johnson K. Labile iron parenteral iron formulations: a quantitative and comparative study. Nephrol Dial Transplant. 2004;19:561-565. Charytan C, Quinibi W, Bailie G. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron, 2005;100:c55-c62. Van Wyck D, Roppolo M, Mazey RM, et.al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int'l. 2005;68:2846-2856 Walters B, Van Wyck D. Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients. Nephrol Dial Transplant. 2005;20:1438-1442 Macdougall I, Roche A. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: A prospective evaluation of 2,297 injections. AJKD. 2005;46:283-289. Schiesser D, Binet I, Dimitrios T, et. al. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. Nephrol Dial Transplant. 2006; 21(10):2841-2845. Singh H, Reed J, Noble S, Cangiano J, Van Wyck D. Effect of Intravenous Iron Sucrose in Peritoneal Dialysis Patients Who Receive Erythropoiesis-Stimulating Agents for Anemia: A Randomized, contolled Trial. Clin J Am Soc Nephrol. 2006; 1:475-482. Reed J, Charytan C, Yee J. The Safety of Intravenous Iron Sucrose Use in the Elderly Patient. The Consult Pharm. 2007;22:230-238. Additional Materials Venofer^® promotional materials The Iron Story (iron deficiency anemia patient education booklet) - English version (to download an electronic copy, please click here) for more information please contact the American Association of Kidney Patients at info@aakp.org) The Iron Story (iron deficiency anemia patient education booklet) - Spanish version (to download an electronic copy, please click here) for more information please contact the American Association of Kidney Patients at info@aakp.org) Venofer^® Dosing Card/Iron Management Flow Chart Venofer^®Compendium CKD Anemia Brochure Ferritin Guide First Name * Last Name * Degree/License Information (choose 1): Specialty/Area of Practice (choose 1): Title Facility/Practice Site Address 1 * Address 2 Address 3 City* Province* (Canada Only) State* Country * Zip Code * E-mail Address Telephone Number Fax Number *Required information.
Full Prescribing Information \| Privacy Policy \| Terms of Use \| Contact Us \| Request Literature \| Glossary © 2010, American Regent, Inc., a Luitpold Pharmaceuticals, Inc., company.